145 related articles for article (PubMed ID: 24386385)
1. A non-biological method for screening active components against influenza virus from traditional Chinese medicine by coupling a LC column with oseltamivir molecularly imprinted polymers.
Yang YJ; Li JY; Liu XW; Zhang JY; Liu YR; Li B
PLoS One; 2013; 8(12):e84458. PubMed ID: 24386385
[TBL] [Abstract][Full Text] [Related]
2. Preparation and Evaluation of Oseltamivir Molecularly Imprinted Polymer Silica Gel as Liquid Chromatography Stationary Phase.
Yang YJ; Liu XW; Kong XJ; Qin Z; Jiao ZH; Li SH; Li JY
Molecules; 2018 Jul; 23(8):. PubMed ID: 30060497
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of potential herb-drug interactions between oseltamivir and commonly used anti-influenza Chinese medicinal herbs.
Zhang Y; Lyu C; Fong SYK; Wang Q; Li C; Ho NJ; Chan KS; Yan X; Zuo Z
J Ethnopharmacol; 2019 Oct; 243():112097. PubMed ID: 31325600
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity of furanocoumarins isolated from Angelica dahurica against influenza a viruses H1N1 and H9N2.
Lee BW; Ha TKQ; Cho HM; An JP; Kim SK; Kim CS; Kim E; Oh WK
J Ethnopharmacol; 2020 Sep; 259():112945. PubMed ID: 32389854
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of hydroalcoholic extract from Eupatorium perfoliatum L. against the attachment of influenza A virus.
Derksen A; Kühn J; Hafezi W; Sendker J; Ehrhardt C; Ludwig S; Hensel A
J Ethnopharmacol; 2016 Jul; 188():144-52. PubMed ID: 27178637
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of oseltamivir derivatives containing pyridyl group as potent inhibitors of neuraminidase for influenza A.
Wang K; Lei Z; Zhao L; Chen B; Yang F; Liu K; Zhu H; Zhao H; Cao R; Zhang K; Tian Y
Eur J Med Chem; 2020 Jan; 185():111841. PubMed ID: 31708183
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of novel oseltamivir derivatives against some influenza virus strains.
Kocik J; Kołodziej M; Joniec J; Kwiatek M; Bartoszcze M
Acta Biochim Pol; 2014; 61(3):509-13. PubMed ID: 25210935
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
[TBL] [Abstract][Full Text] [Related]
9. Identification of small molecules acting against H1N1 influenza A virus.
Agamennone M; Pietrantoni A; Superti F
Virology; 2016 Jan; 488():249-58. PubMed ID: 26655243
[TBL] [Abstract][Full Text] [Related]
10. Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1.
Neri-Bazán RM; García-Machorro J; Méndez-Luna D; Tolentino-López LE; Martínez-Ramos F; Padilla-Martínez II; Aguilar-Faisal L; Soriano-Ursúa MA; Trujillo-Ferrara JG; Fragoso-Vázquez MJ; Barrón BL; Correa-Basurto J
Eur J Med Chem; 2017 Mar; 128():154-167. PubMed ID: 28182988
[TBL] [Abstract][Full Text] [Related]
11. Novel daidzein analogs and their in vitro anti-influenza activities.
Chung ST; Huang YT; Hsiung HY; Huang WH; Yao CW; Lee AR
Chem Biodivers; 2015 Apr; 12(4):685-96. PubMed ID: 25879510
[TBL] [Abstract][Full Text] [Related]
12. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.
Li Z; Meng Y; Xu S; Shen W; Meng Z; Wang Z; Ding G; Huang W; Xiao W; Xu J
Bioorg Med Chem; 2017 May; 25(10):2772-2781. PubMed ID: 28385598
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of aprotinin on influenza A and B viruses in vitro and in vivo.
Song EJ; Españo E; Shim SM; Nam JH; Kim J; Lee K; Park SK; Lee CK; Kim JK
Sci Rep; 2021 May; 11(1):9427. PubMed ID: 33941825
[TBL] [Abstract][Full Text] [Related]
14. Amazonian Siparuna extracts as potential anti-influenza agents: Metabolic fingerprinting.
Leal CM; Simas RC; Miranda M; Campos MF; Gomes BA; Siqueira MM; Vale GD; Gomes de Almeida CV; Leitão SG; Leitão GG
J Ethnopharmacol; 2021 Apr; 270():113788. PubMed ID: 33429033
[TBL] [Abstract][Full Text] [Related]
15. Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant.
Zhang J; Murugan NA; Tian Y; Bertagnin C; Fang Z; Kang D; Kong X; Jia H; Sun Z; Jia R; Gao P; Poongavanam V; Loregian A; Xu W; Ma X; Ding X; Huang B; Zhan P; Liu X
J Med Chem; 2018 Nov; 61(22):9976-9999. PubMed ID: 30365885
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of Poncirus trifoliata seed extract against oseltamivir-resistant influenza virus.
Heo Y; Cho Y; Ju KS; Cho H; Park KH; Choi H; Yoon JK; Moon C; Kim YB
J Microbiol; 2018 Aug; 56(8):586-592. PubMed ID: 30047088
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of novel reassortant avian influenza H7N9 virus infection in vitro with three antiviral drugs, oseltamivir, peramivir and favipiravir.
Cao RY; Xiao JH; Cao B; Li S; Kumaki Y; Zhong W
Antivir Chem Chemother; 2014 Dec; 23(6):237-40. PubMed ID: 23948557
[TBL] [Abstract][Full Text] [Related]
18. Use of embryonated chicken egg as a model to study the susceptibility of avian influenza H9N2 viruses to oseltamivir carboxylate.
Tare DS; Pawar SD
J Virol Methods; 2015 Nov; 224():67-72. PubMed ID: 26297959
[TBL] [Abstract][Full Text] [Related]
19. The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses.
Leneva IA; Roberts N; Govorkova EA; Goloubeva OG; Webster RG
Antiviral Res; 2000 Nov; 48(2):101-15. PubMed ID: 11114412
[TBL] [Abstract][Full Text] [Related]
20. Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses.
Govorkova EA; Leneva IA; Goloubeva OG; Bush K; Webster RG
Antimicrob Agents Chemother; 2001 Oct; 45(10):2723-32. PubMed ID: 11557461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
